Evidence-Based Review of Data on the Combination Inhaler Umeclidinium/Vilanterol in Patients With COPD

International Journal of COPD - New Zealand
doi 10.2147/copd.s191845
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Patient Considerations in the Treatment of COPD: Focus on the New Combination Inhaler Umeclidinium/Vilanterol

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2015English

Single-Inhaler Triple Therapy Utilizing the Once-Daily Combination of Fluticasone Furoate, Umeclidinium and Vilanterol in the Management of COPD: The Current Evidence Base and Future Prospects

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2018English

Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2020English

Initial Inhaler Choice in COPD: Real-World Evidence

Breathe
PulmonaryRespiratory Medicine
2019English

P275 Comparing Clinically Relevant Improvement With Umeclidinium/Vilanterol and Tiotropium/Olodaterol in Symptomatic Copd: A Randomised Non-Inferiority Crossover Trial

2017English

Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial

PLoS ONE
Multidisciplinary
2015English

Prs21 - Economic Impact of Delaying Initiation With Multiple Inhaler Maintenance Triple Therapy Treatment in Spanish Copd Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Comparative Efficacy of Umeclidinium Bromide Versus Other Long-Acting Anticholinergic Monotherapies as Treatments for Copd Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Benefits of a Comprehensive COPD Inhaler Identification Aid

Prescriber
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy